Medications & Supplements/Prescription Drugs

Desmopressin Acetate Tablets Recalled for Subpotency

Agency Publication Date: December 7, 2022

Summary

RemedyRepack Inc. has recalled nine 100-count boxes of Desmopressin Acetate tablets (0.2 mg) because the medication was found to be subpotent. Subpotency means the product may contain less than the required amount of active ingredient, potentially reducing its effectiveness. These tablets were repackaged from a product originally manufactured by Avet Pharmaceuticals and distributed to two customers in Michigan.

Risk

If the medication is subpotent, it may not effectively treat the medical condition for which it was prescribed, potentially leading to a return of symptoms. No incidents or injuries have been reported to date.

What You Should Do

This recall affects 100-count boxes of Desmopressin Acetate tablets (0.2 mg) repackaged by RemedyRepack Inc. (NDC 70518-3493-00).
Check the labeling on your prescription bottle or carton for lot numbers B1817019-082222 (Expiration 02/24/2023) or B1819127-082322 (Expiration 02/26/2023).
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact RemedyRepack Inc. for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 for more information regarding this recall.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Desmopressin Acetate Tablet, 0.2 mg (100-count box)

Variants: 0.2 mg, Tablet, 100-count box

Lot Numbers:

B1817019-082222 (Exp. 02/24/2023)

B1819127-082322 (Exp. 02/26/2023)

NDC:

70518-3493-00

23155-0490-01

Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 91263

Status: Resolved

Manufacturer: RemedyRepack Inc.

Sold By: Specialty pharmacies; Healthcare providers

Manufactured In: United States

Units Affected: 9 boxes

Distributed To: Michigan

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects 100-count boxes of Desmopressin Acetate tablets (0.2 mg) repackaged by RemedyRepack Inc. (NDC 70518-3493-00).

Check the labeling on your prescription bottle or carton for lot numbers B1817019-082222 (Expiration 02/24/2023) or B1819127-082322 (Expiration 02/26/2023).

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact RemedyRepack Inc. for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 for more information regarding this recall.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Desmopressin Acetate Tablet, 0.2 mg (100-count box)

Variants: 0.2 mg, Tablet, 100-count box

Lot Numbers:

B1817019-082222 (Exp. 02/24/2023)

B1819127-082322 (Exp. 02/26/2023)

NDC:

70518-3493-00

23155-0490-01

Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701.